Status:
COMPLETED
Validation of the French Version of the Score on Quality of Life (HiSQOL) in Hidradenitis Suppurativa (QUALIVER)
Lead Sponsor:
University Hospital, Brest
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
18+ years
Brief Summary
Validation of the French Version of the Score on Quality of Life in Hidradenitis Suppurativa. The French HiSQOL will be completed by 60 patients with hidradenitis suppurativa a first time, and a secon...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Patient with Verneuil disease
- Beneficiary of or affiliated to a social security insurance
- Participation agreement
Exclusion
- Patients physically or mentally unable to complete questionnaires.
- Refusal to participate
- Patient under legal protection (guardianship, curatorship) or deprived of liberty
Key Trial Info
Start Date :
August 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 22 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05986825
Start Date
August 29 2023
End Date
December 22 2023
Last Update
July 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brest
Brest, France, 29200